Sildenafil
Product Images NDC 76519-1135

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 76519-1135). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by H. J. Harkins Company Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

76519 1135.jpg (76519 1135)

Label for Sildenafil Citrate 20mg tablets, repackaged by H. J. Harkins Company Inc. The label includes the product name, strength (20mg), dosage form (tablet), NDC 76519-1135-XX, expiration date 03/31/19, and lot number BSM710A. Barcodes and caution statements regarding prescription use and storage are also visible.*

FDA Label Image

Figure 6.jpg (Figure 6)

A Kaplan-Meier survival curve graph showing estimated cumulative mortality rates over 5 years for three dosage groups: high dose, medium dose, and low dose. The x-axis represents time in years, and the y-axis represents cumulative mortality rate percentage, with numbers at risk listed above the graph for each group over time.*

FDA Label Image

Sildenafil.jpg (Sildenafil)

Chemical structure of sildenafil as shown in the diagram. The structure illustrates the molecular arrangement of atoms and bonds characteristic of sildenafil, including functional groups and the arrangement of nitrogen, oxygen, carbon, and sulfur atoms.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.